EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting MYC induces lipid droplet accumulation by upregulation of HILPDA in clear cell renal cell carcinoma

Lourdes Sainero-Alcolado iD, Elisa Garde-Lapido iD, Marteinn Thor Snaebjörnsson, Sarah Schoch, Irene Stevens iD, María Victoria Ruiz-Pérez, Christine Dyrager iD, Vicent Pelechano, Håkan Axelson iD, Almut Schulze, Marie Arsenian-Henriksson iD

Proceedings of the National Academy of Sciences · 13.02.2024 · 121 (7)

DOI: 10.1073/pnas.2310479121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 09.02.2024. Verfasst von Lourdes Sainero-Alcolado und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Tumor and Cell Biology, Biomedicum B7, Karolinska Institutet, Stockholm 17165, Sweden. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Lipid Droplets, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation), VINNOVA (Swedish Governmental Agency for Innovation Systems), Vetenskapsrådet (VR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic reprogramming is critical during clear cell renal cell carcinoma (ccRCC) tumorigenesis, manifested by accumulation of lipid droplets (LDs), organelles that have emerged as new hallmarks of cancer. Yet, regulation of their biogenesis is still poorly understood. Here, we demonstrate that MYC inhibition in ccRCC cells lacking the von Hippel Lindau ( VHL ) gene leads to increased triglyceride content potentiating LD formation in a glutamine-dependent manner. Importantly, the concurrent inhibition of MYC signaling and glutamine metabolism prevented LD accumulation and reduced tumor burden in vivo. Furthermore, we identified the hypoxia-inducible lipid droplet–associated protein (HILPDA) as the key driver for induction of MYC-driven LD accumulation and demonstrated that conversely, proliferation, LD formation, and tumor growth are impaired upon its downregulation. Finally, analysis of ccRCC tissue as well as healthy renal control samples postulated HILPDA as a specific ccRCC biomarker. Together, these results provide an attractive approach for development of alternative therapeutic interventions for the treatment of this type of renal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsLipid DropletsProto-Oncogene Proteins c-mycHumansCell Line, TumorGene Expression Regulation, NeoplasticGlutamineSignal TransductionUp-RegulationVon Hippel-Lindau Tumor Suppressor ProteinNeoplasm Proteins

Stichwörter der Autor:innen

HILPDAMYCclear cell renal cell carcinomaglutaminelipid droplets

Substanzen

GlutamineHILPDA protein, humanProto-Oncogene Proteins c-mycVon Hippel-Lindau Tumor Suppressor ProteinNeoplasm Proteins

Autor:innen und Institutionen

  • Department of Microbiology, Tumor and Cell Biology, Biomedicum B7, Karolinska Institutet, Stockholm 17165, Sweden.
  • Division of Tumor Metabolism and Microenvironment, German Cancer Research Center, Heidelberg 69120, Germany.
  • Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund 22100, Sweden.
  • Science for Life Laboratory, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 17165, Sweden.
  • Department of Chemistry-Biomedical Centre, Uppsala University, Uppsala 75123, Sweden.

ORCID-Profile: Lourdes Sainero-Alcolado, Elisa Garde-Lapido, Irene Stevens, Christine Dyrager, Håkan Axelson, Marie Arsenian-Henriksson

Förderung

  • Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)
  • VINNOVA (Swedish Governmental Agency for Innovation Systems)
  • Vetenskapsrådet (VR)
  • Robert Lundbergs Minnesstiftelse (Robert Lundberg Memorial Foundation)
  • Deutsche Forschungsgemeinschaft (DFG)
  • Deutsche Krebshilfe (German Cancer Aid)
  • Barncancerfonden (Swedish Childhood Cancer Foundation)
  • Cancerfonden (Swedish Cancer Society)

Zitieren

APA

Sainero-Alcolado, L., Garde-Lapido, E., Snaebjörnsson, M. T., Schoch, S., Stevens, I., Ruiz-Pérez, M. V., Dyrager, C., Pelechano, V., Axelson, H., Schulze, A., & Arsenian-Henriksson, M. (2024). Targeting MYC induces lipid droplet accumulation by upregulation of HILPDA in clear cell renal cell carcinoma. Proceedings of the National Academy of Sciences, 121(7). https://doi.org/10.1073/pnas.2310479121

Vancouver

Sainero-Alcolado L, Garde-Lapido E, Snaebjörnsson MT, Schoch S, Stevens I, Ruiz-Pérez MV, et al. Targeting MYC induces lipid droplet accumulation by upregulation of HILPDA in clear cell renal cell carcinoma. Proceedings of the National Academy of Sciences. 2024;121(7). doi:10.1073/pnas.2310479121

BibTeX
@article{SaineroAlcolado2024,
  author = {Sainero-Alcolado, Lourdes and Garde-Lapido, Elisa and Snaebjörnsson, Marteinn Thor and Schoch, Sarah and Stevens, Irene and Ruiz-Pérez, María Victoria and Dyrager, Christine and Pelechano, Vicent and Axelson, Håkan and Schulze, Almut and Arsenian-Henriksson, Marie},
  title = {Targeting MYC induces lipid droplet accumulation by upregulation of HILPDA in clear cell renal cell carcinoma},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {7},
  doi = {10.1073/pnas.2310479121}
}
Kostenlos starten →